ArticleNeuro-oncology advances

A phase III double-blind placebo-controlled randomized study of dexamphetamine sulfate for fatigue in primary brain tumors patients: An ANOCEF trial (DXA).

Florence Laigle-Donadey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.